Skip to main content
. Author manuscript; available in PMC: 2010 Mar 22.
Published in final edited form as: J Nanosci Nanotechnol. 2005 Dec;5(12):1964–1982. doi: 10.1166/jnn.2005.446

Fig. 11.

Fig. 11

Animal trials for cancer therapy using the fabricated RNA nanoparticles. (A) Injection without the pRNA/siRNA chimera (No RNA); (B) Treatment with RNA chimera containing folate-pRNA and siRNA(Survivin); (C) Treatment with RNA chimera containing folate-pRNA and siRNA(Survivin) with mutations in the siRNA sequence; (D) Treatment with pRNA-siRNA chimera that does not contain a folate at its 5′ end. Reprinted with permission from [47], A. Khaled et al., Nano Lett. 5, 1797 (2005). © 2005, American Chemical Society.